AAAAAA
Results: 101-125/396
Authors:
HAHKAKEMPPINEN M
MUHONEN T
NORDLING S
PYRHONEN S
Citation: M. Hahkakemppinen et al., DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA, Melanoma research, 7(4), 1997, pp. 329-334
Authors:
BACCARD M
HAVARD S
SOUQUES M
Citation: M. Baccard et al., PROSPECTIVE-STUDY OF THE INCIDENCE OF MELANOMA IN THE PARIS REGION IN1994, Melanoma research, 7(4), 1997, pp. 335-338
Authors:
BLIZZARD L
DWYER T
ASHBOLT R
Citation: L. Blizzard et al., CHANGES IN SELF-REPORTED SKIN TYPE ASSOCIATED WITH EXPERIENCE OF SUNBURNING IN 14-15 YEAR-OLD CHILDREN OF NORTHERN EUROPEAN DESCENT, Melanoma research, 7(4), 1997, pp. 339-346
Authors:
BRANDBERG Y
SJODEN PO
ROSDAHL I
Citation: Y. Brandberg et al., ASSESSMENT OF SUN-RELATED BEHAVIOR IN INDIVIDUALS WITH DYSPLASTIC NEVUS SYNDROME - A COMPARISON BETWEEN DIARY RECORDINGS AND QUESTIONNAIRE RESPONSES, Melanoma research, 7(4), 1997, pp. 347-351
Authors:
LEE JAH
Citation: Jah. Lee, LATITUDE, COASTAL OR INTERIOR LOCATION AND THE EVOLUTION OF THE MELANOMA EPIDEMIC IN THE UNITED-STATES, Melanoma research, 7(3), 1997, pp. 179-188
Authors:
EDWARD M
GODDEN JL
ALEXANDER CL
MACKIE PM
Citation: M. Edward et al., EFFECT OF RETINOIC ACID ON MELANOMA CELL-DERIVED FACTOR STIMULATION OF FIBROBLAST GLYCOSAMINOGLYCAN SYNTHESIS, Melanoma research, 7(3), 1997, pp. 189-196
Authors:
MILLER JG
GEE J
PRICE A
GARBE C
MACNEIL S
Citation: Jg. Miller et al., INVESTIGATION OF ESTROGEN-RECEPTORS, SEX STEROIDS AND SOLUBLE ADHESION MOLECULES IN THE PROGRESSION OF MALIGNANT-MELANOMA, Melanoma research, 7(3), 1997, pp. 197-208
Authors:
TRON VA
CRAWFORD R
VIELKIND JR
Citation: Va. Tron et al., THE MELANOMA-SPECIFIC XMEL ANTIGEN IS EXPRESSED IN DYSPLASTIC NEVI, Melanoma research, 7(3), 1997, pp. 209-213
Authors:
KRULL F
HOLZER U
IHLE J
BETHGE W
FIERLBECK G
KALLAND T
DOHLSTEN M
NIETHAMMER D
DANNECKER GE
Citation: F. Krull et al., SUPERANTIGEN-INDUCED LYSIS OF MELANOMA-CELLS, Melanoma research, 7(3), 1997, pp. 214-222
Authors:
DEKKER SK
VINK J
BRUIJN JA
MIHM MC
VERMEER BJ
BYERS HR
Citation: Sk. Dekker et al., CHARACTERIZATION OF INTERLEUKIN-1-ALPHA-INDUCED MELANOMA CELL MOTILITY - INHIBITION BY TYPE-I AND TYPE-II RECEPTOR-BLOCKING MONOCLONAL-ANTIBODIES, Melanoma research, 7(3), 1997, pp. 223-230
Authors:
GRECO IM
CALVISI G
VENTURA L
CERRITO F
Citation: Im. Greco et al., AN IMMUNOHISTOCHEMICAL ANALYSIS OF NM23 GENE-PRODUCT EXPRESSION IN UVEAL MELANOMA, Melanoma research, 7(3), 1997, pp. 231-236
Authors:
LANE AM
EGAN KM
YANG J
SAORNIL MA
ALROY J
ALBERT D
GRAGOUDAS ES
Citation: Am. Lane et al., AN EVALUATION OF TUMOR VASCULARITY AS A PROGNOSTIC INDICATOR IN UVEALMELANOMA, Melanoma research, 7(3), 1997, pp. 237-242
Authors:
HASEGAWA M
TAKATA M
HATTA N
WAKAMATSU K
ITO S
TAKEHARA K
Citation: M. Hasegawa et al., SIMULTANEOUS MEASUREMENT OF SERUM 5-S-CYSTEINYLDOPA, CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN JAPANESE PATIENTS WITH MALIGNANT-MELANOMA, Melanoma research, 7(3), 1997, pp. 243-251
Authors:
WU ZY
SMITHERS BM
ROBERTS MS
Citation: Zy. Wu et al., MELPHALAN DOSING REGIMENS FOR MANAGEMENT OF RECURRENT MELANOMA BY ISOLATED LIMB PERFUSION - APPLICATION OF A PHYSIOLOGICAL PHARMACOKINETIC MODEL-BASED ON MELPHALAN DISTRIBUTION IN THE ISOLATED-PERFUSED RAT HINDLIMB, Melanoma research, 7(3), 1997, pp. 252-264
Authors:
SAKAI C
KAWAKAMI Y
LAW LW
FURUMURA M
HEARING VJ
Citation: C. Sakai et al., MELANOSOMAL PROTEINS AS MELANOMA-SPECIFIC IMMUNE TARGETS, Melanoma research, 7(2), 1997, pp. 83-95
Authors:
SEXTON PS
COX JL
Citation: Ps. Sexton et Jl. Cox, INHIBITION OF MOTILITY AND INVASION OF B16 MELANOMA BY THE OVEREXPRESSION OF CYSTATIN-C, Melanoma research, 7(2), 1997, pp. 97-101
Authors:
BLOM DJR
DEWAARDSIEBINGA I
APTE RS
LUYTEN GPM
NIEDERKORN JY
JAGER MJ
Citation: Djr. Blom et al., EFFECT OF HYPERTHERMIA ON EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS AND HEAT-SHOCK-PROTEIN MOLECULES ON 3 HUMAN OCULAR MELANOMA CELL-LINES, Melanoma research, 7(2), 1997, pp. 103-109
Authors:
HANEKOM GS
JOHNSON CA
KIDSON SH
Citation: Gs. Hanekom et al., AN IMPROVED AND COMBINED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSAY FOR RELIABLE DETECTION OF METASTATIC MELANOMA-CELLS IN PERIPHERAL-BLOOD, Melanoma research, 7(2), 1997, pp. 111-116
Authors:
BONI R
LICHTENSTEIGER W
STEINERT HC
BONI RAH
FRUH H
DUMMER R
HARTMANN DG
LAINE E
BURG G
Citation: R. Boni et al., D1 DOPAMINE-RECEPTORS ARE NOT EXPRESSED IN HUMAN-MELANOMA, Melanoma research, 7(2), 1997, pp. 117-119
Authors:
VANDENOORD JJ
MAES A
STAS M
NUYTS J
DEWEVER I
DEWOLFPEETERS C
Citation: Jj. Vandenoord et al., PROGNOSTIC-SIGNIFICANCE OF NM23 PROTEIN EXPRESSION IN MALIGNANT-MELANOMA - AN IMMUNOHISTOCHEMICAL STUDY, Melanoma research, 7(2), 1997, pp. 121-128
Authors:
RICHARDSON PSR
COOKE K
GERRISH P
REES RC
RENNIE IG
Citation: Psr. Richardson et al., NATURAL-KILLER AND LYMPHOKINE-ACTIVATED CYTOTOXICITY FOLLOWING ANESTHESIA IN PATIENTS WITH UVEAL MALIGNANT-MELANOMA, Melanoma research, 7(2), 1997, pp. 129-137
Authors:
HAKANSSON A
GUSTAFSSON B
KRYSANDER L
BERGENWALD C
SANDER B
HAKANSSON L
Citation: A. Hakansson et al., EFFECT OF INTERFERON-ALPHA ON THE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA BY METASTATIC MALIGNANT-MELANOMA IN-VIVO, Melanoma research, 7(2), 1997, pp. 139-145
Authors:
SCHULTZ MZ
BUZAID AC
POO WJ
Citation: Mz. Schultz et al., A PHASE-II STUDY OF INTERFERON-ALPHA-2B WITH DACARBAZINE, CARMUSTINE,CISPLATIN AND TAMOXIFEN IN METASTATIC MELANOMA, Melanoma research, 7(2), 1997, pp. 147-151
Authors:
RETSAS S
FALKSON C
Citation: S. Retsas et C. Falkson, 2ND INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPY OF MALIGNANT-MELANOMA - LONDON, UK, 14-15 MARCH, 1997, Melanoma research, 7(2), 1997, pp. 153-155
Citation: ABSTRACTS OF THE 2ND INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPYOF MALIGNANT-MELANOMA - LONDON, UK, 14-15 MARCH, 1997, Melanoma research, 7(2), 1997, pp. 156-172